JOEL S MARCUS
CIK 1216955 · Executive Chairman · last filed 2026-05-07
JOEL S MARCUS is an Executive Chairman who has filed 284 SEC Form 4 insider transactions across 9 companies since 2007. The most recent filing shows the insider bought $347.6K of ARE on May 7, 2026. Across all open-market trades the lifetime net is −$156.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $51.0M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$51.03M
9
284
-$156.07M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ARE | Executive Chairman | 587,724 | $53.17 | $31.25M | -$77.93M | 157 | 2026-05-07 |
| Intra-Cellular Therapies, Inc. (ITCI) Delisted | Director | 0 | $131.87 | $0 | -$13.07M | 43 | 2025-04-02 |
| Applied Therapeutics, Inc. (APLT) Delisted | Director | 565,849 | $0.10 | $58.3K | -$257.6K | 15 | 2024-06-07 |
| Korro Bio, Inc. (FREQ) Delisted | Director | 1,318,846 | $14.98 | $19.76M | -$1.32M | 11 | 2022-08-19 |
| MGTX | Director | 1,995,608 | $9.59 | $19.14M | -$294.2K | 7 | 2022-06-09 |
| ALEXANDRIA REAL ESTATE EQUITIES, INC. (AREpD) Delisted | Executive Chairman | 445,962 | — | — | -$61.81M | 36 | 2019-09-10 |
| ATRA | Director | 11,500 | $10.41 | $119.7K | -$1.52M | 12 | 2019-03-19 |
| REXR | Director | 12,858 | $35.09 | $451.2K | $140.0K | 1 | 2013-07-24 |
| PMT | Director | 7,000 | $10.12 | $70.8K | $0 | 2 | 2012-05-18 |
Recent Filings
284 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-07 | ARE | Buy (P) | +7,500 | $347.6K | EDGAR |
| 2026-05-06 | ARE | Buy (P) | +7,500 | $320.4K | EDGAR |
| 2026-05-05 | ARE | Buy (P) | +10,000 | $410.2K | EDGAR |
| 2026-02-13 | ARE | Buy (P) | +25,000 | $1.35M | EDGAR |
| 2026-01-26 | ARE | Disp (D) | −49,746 | $0 | EDGAR |
| 2026-01-13 | ARE | Grant (A) | +100,056 | $0 | EDGAR |
| 2026-01-05 | ARE | Grant (A) | +31,270 | $0 | EDGAR |
| 2025-04-02 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Disp (D) | −58,238 | -$7.69M | EDGAR |
| 2025-02-26 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Exer (M) | +7,009 | $447.1K | EDGAR |
| 2025-01-14 | ARE | Grant (A) | +46,207 | $0 | EDGAR |